Alere (ALR) Reports Q1 GAAP Loss of $0.80/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Alere Reports First Quarter 2017 Financial Results
June 14, 2017 4:15 PM EDTWALTHAM, Mass., June 14, 2017 /PRNewswire/ --Â Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced its financial results for the first quarter ended March 31, 2017.
First Quarter 2017 Results                                                                                                 Â
Total revenue was $588 million, compared to $587 million in the prior year period. Global influenza sales were $59 million in the first quarter of 2017, a 118% increase compared to $27 million in the prior year period. Non-GAAP organic growth during the first quarter of 2017 was +0.9%, or +6.8% excluding Arriva*. Negative impact of foreign currency exchange was $5 million in the first quarter of 2017. GAAP loss from continuing operations during the first... More